J9119 HCPCS code: Injection, cemiplimab-rwlc, 1 mg
J9119 is the HCPCS Level II code for injection, cemiplimab-rwlc, 1 mg. In 2024 Medicare paid an average of $21.50 per service for J9119 across 6,304,608 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 700 per day on outpatient hospital claims. Medicare volume rose 92% from 2022 to 2024 (3,275,850 to 6,304,608 services). In 2024, about 2,266 clinicians billed Medicare for J9119 for 2,690 beneficiaries; Florida, Texas, California accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2019-10-01 |
| Last action effective | 2019-10-01 |
Who bills J9119 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,266 |
| Medicare beneficiaries | 2,690 |
| States with claims | 38 |
| Share of services in top 3 states (Florida, Texas, California) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9119, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,275,850 | 1,428 | $26.85 | $21.43 |
| 2023 | 4,951,943 | 2,187 | $26.32 | $20.97 |
| 2024 | 6,304,608 | 2,690 | $26.99 | $21.50 |
States with the most J9119 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,066,474 | $21.62 |
| Texas | 563,140 | $21.64 |
| California | 535,862 | $21.20 |
| Illinois | 421,750 | $21.69 |
| Tennessee | 354,203 | $21.72 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 700 | Prescribing Information |
| practitioner claims | 700 | Prescribing Information |
What changed for J9119
- 2019-10-01: J9119 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9119?
J9119 is the HCPCS Level II code for injection, cemiplimab-rwlc, 1 mg. Short descriptor: "Inj., cemiplimab-rwlc, 1 mg".
How much does Medicare pay for J9119?
In 2024, the average Medicare payment was $21.50 per service (average allowed $26.99).
Does Medicare cover J9119?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9119 can be billed per day?
700 on outpatient hospital claims; 700 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
- J9161 — Injection, denileukin diftitox-cxdl, 1 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9119
- Watch J9119 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9119
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.